4000-520-616
欢迎来到免疫在线！(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
产品库 品牌馆 现货促销 技术交流 新闻动态 联系我们
MedChemExp
主营：主营：抑制剂、激动剂、API
咨询热线电话
4000-520-616
公司首页 公司介绍 产品中心 新闻动态 联系方式 在线下单
当前位置： 首页 > 产品中心 > Small_molecule > Medchemexpress/Simvastatin(Synonyms: MK 733)/HY-17502/50mg
商品详细Medchemexpress/Simvastatin(Synonyms: MK 733)/HY-17502/50mg
Medchemexpress/Simvastatin(Synonyms: MK 733)/HY-17502/50mg
Medchemexpress/Simvastatin(Synonyms: MK 733)/HY-17502/50mg
商品编号： HY-17502-10mM*1mLinDMSO
品牌： MedChemExp
市场价： ¥1580.00
美元价： 948.00
产地： 美国(厂家直采)
公司：
产品分类： 小分子
公司分类： Small_molecule
联系Q Q： 3392242852
电话号码： 4000-520-616
电子邮箱： info@ebiomall.com
立即询价
商品介绍
SimvastatinisacompetitiveinhibitorofHMG-CoAreductasewithKdof0.1-0.2nM.

CustomerValidation

  • •OxidMedCellLongev.24July2017.
Description

SimvastatinisacompetitiveinhibitorofHMG-CoAreductasewithKdof0.1-0.2nM.

IC50&Target

Ki:0.1-0.2nM(HMG-CoAreductase)

InVitro

Priortouseincellassays,simvastatinneedstobeactivatedbyNaOHinEtOHtreatment.SimvastatininhibitscholesterolsynthesisinmouseL-Mcell(fibroblast),ratH4IIEcell(liver),andhumanHepG2cell(liver)withIC50of19.3nM,13.3nMand15.6nM,respectively[1].Simvastatintreatmentleadstoadose-dependentincreaseinserine473phosphorylationofAktwithin30minutes,withmaximalphosphorylationoccurringat1.0µM.Simvastatin(1.0μM)enhancesphosphorylationoftheendogenousAktsubstrateendothelialnitricoxidesynthase(eNOS),inhibitsserum-freemediaundergoapoptosisandacceleratesvascularstructureformation[2].Simvastatindisplaysanti-inflammatoryeffectsinvitro.Simvastatin(10μM)reducesanti-CD3/anti-CD28antibody-stimulatedproliferationofPB-derivedmononuclearcellsandsynovialfluidcellsfromrheumatoidarthritisblood,aswellasIFN-γrelease.Simvastatin(10μM)suppressescell-mediatedmacrophageTNF-γreleaseinducedviacognateinteractionsbyappr30%[3].

InVivo

SimvastatinorallyadmiNISTrationinhibitstheconversionofrADIolabeledacetatetocholesterolwithIC50of0.2mg/kg[1].Simvastatin(4mg/day)orallyadministrationfor13weekstorabbitsfedanatherogencicholesterol-richdiet,returnsthecholesterol-inducedincreasesintotalcholesterol,LDL-cholesterolandHDL-cholesteroltonormallevel[4]. Simvastatin(6mg/kg)producesanincreaseinLDLreceptor-dependentbindingandincreasesthenumberofhepaticLDLreceptorsinrabbitsfedadietcontaining0.25%cholesterol[5].Simvastatininfluencesinflammationindependentofitseffectonplasmacholesterollevel.Incynomolgusmonkeysconsumedanatherogenicdiet,Simvastatin(20mg/kg/day)inducesa1.3-foldlessmacrophagecontentinlesions,and2-foldlessvascularcelladhesionmolecule-1,interleukin-1beta,andtissuefactorexpression,companiedbya2.1-foldincreasesinlesionalsmoothmusclecellandcollagencontent[6].

ClinicalTrial
ViewMoreCollapse
References

  • [1].Slater,E.E.,etal.MechanismofactionandBIOLOGicalprofileofHMGCoAreductaseinhibitors.Anewtherapeuticalternative.Drugs,1988.36Suppl3:p.72-82.

    [2].Kureishi,Y.,etal.TheHMG-CoAreductaseinhibitorsimvastatinactivatestheproteinkinaseAktandpromotesangiogenesisinnormocholesterolemicanimals.NatMed,2000.6(9):p.1004-10.

    [3].LeungBP,etal.Anovelanti-inflammatoryroleforsimvastatinininflammatoryarthritis.JImmunol.2003Feb1;170(3):1524-30.

    [4].KobayashiM,etal.PreventiveeffectofMK-733(simvastatin),aninhibitorofHMG-CoAreductase,onhypercholesterolemiaandatherosclerosisinducedbycholesterolfeedinginrabbits.JpnJPharmacol.1989Jan;49(1):125-33.

    [5].IshidaF,etal.Comparativeeffectsofsimvastatin(MK-733)andpravastatin(CS-514)onhypercholesterolemiainducedbycholesterolfeedinginrabbits.BiochimBiophysActa.1990Feb23;1042(3):365-73.

    [6].SukhovaGK,etal.Statinsreduceinflammationinatheromaofnonhumanprimatesindependentofeffectsonserumcholesterol.ArteriosclerThrombVascBiol.2002Sep1;22(9):1452-8.

    [7].ZhongzhongLiu,etal.PretreatmentDonorsafterCirculatoryDeathwithSimvastatinAlleviatesLiverIschemiaReperfusionInjuryThroughaKLF2-dependentMechanisminRat.OxidMedCellLongev.24July2017.

PreparingStockSolutions
ConcentrationVolumeMass1mg5mg10mg
1mM2.3891mL11.9454mL23.8909mL
5mM0.4778mL2.3891mL4.7782mL
10mM0.2389mL1.1945mL2.3891mL
Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent.
KinaseAssay
[3]

ForassessmentofAktproteinkinaseactivityinvitro,substrate(2μghistoneH2Bor25μgeNOSpeptide)isincubatedwithAktimmunoprecipitatedfromcelllysateusinggoatpolyclonalanti-Akt1antibody.KinasereactionsareinitiatedfollowingtheadditionofreactioncomponentstoafinalconcentrationofATP(50μM)containing10μCiof32P-γATP,dithiotreitol(1mM),HEPESbuffer(20mM,pH7.4),MnCl2(10mM),MgCl2(10mM).Afterincubationfor30minat30°C,phosphorylatedhistoneH2BisvisualizedafterSDS-PAGE(15%)andautoradiography.Toestimatetheextentof32PincorporationintoeNOSpeptides,eachreactionmixtureismeasuredbyspottingontophosphocellulosediscfilterandtheamountofphosphateincorporatedismeasuredbyCerenkovcounting.Thewild-typepeptidesequenceis1174-RIRTQSFSLQERHLRGAVPWA-1194,andthemutanteNOSpeptideisidenticalexceptthatserine1179issubstitutedbyalanine.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.

AnimalAdministration
[1]

Thirty-nineadultmalecynomolgusmonkeysareinitiallyfedamoderatelyatherogenicdietcontaining0.28mgcholesterolpercalorieofdiet,with16.7%fromprotein,45.1%fromlipids,and38.1%fromcarbohydrates.Afterconsumingtheatherogenicdietfor3months,themonkeysaredividedinto3groups(n=13each)thatareequivalentintheirtotalplasmacholesterol(TPC),LDL-C,andHDLcholesterol(HDL-C)concentrations;thesegroupsconsumetheatherogenicdietandreceivestatin(orcontrol)treatmentforanadditional15months.Controlmonkeysarefedtheatherogenicdietwithnoaddedstatins.Prava-treatedmonkeyshave40mgPrava/kgbodywtperdayaddedtotheatherogenicdiet.Simvastatin(Simva)-treatedmonkeysconsumed20mgSimva/kgbodywtperday.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.

References

  • [1].Slater,E.E.,etal.MechanismofactionandbiologicalprofileofHMGCoAreductaseinhibitors.Anewtherapeuticalternative.Drugs,1988.36Suppl3:p.72-82.

    [2].Kureishi,Y.,etal.TheHMG-CoAreductaseinhibitorsimvastatinactivatestheproteinkinaseAktandpromotesangiogenesisinnormocholesterolemicanimals.NatMed,2000.6(9):p.1004-10.

    [3].LeungBP,etal.Anovelanti-inflammatoryroleforsimvastatinininflammatoryarthritis.JImmunol.2003Feb1;170(3):1524-30.

    [4].KobayashiM,etal.PreventiveeffectofMK-733(simvastatin),aninhibitorofHMG-CoAreductase,onhypercholesterolemiaandatherosclerosisinducedbycholesterolfeedinginrabbits.JpnJPharmacol.1989Jan;49(1):125-33.

    [5].IshidaF,etal.Comparativeeffectsofsimvastatin(MK-733)andpravastatin(CS-514)onhypercholesterolemiainducedbycholesterolfeedinginrabbits.BiochimBiophysActa.1990Feb23;1042(3):365-73.

    [6].SukhovaGK,etal.Statinsreduceinflammationinatheromaofnonhumanprimatesindependentofeffectsonserumcholesterol.ArteriosclerThrombVascBiol.2002Sep1;22(9):1452-8.

    [7].ZhongzhongLiu,etal.PretreatmentDonorsafterCirculatoryDeathwithSimvastatinAlleviatesLiverIschemiaReperfusionInjuryThroughaKLF2-dependentMechanisminRat.OxidMedCellLongev.24July2017.

MolecularWeight

418.57

Formula

C₂₅H₃₈O₅

CASNo.

79902-63-9

Storage
Powder-20°C3years
 4°C2years
Insolvent-80°C6months
 -20°C1month
Shipping

RoomtemperatureincontinentalUS;mayvaryelsewhere

Solvent&Solubility

10mMinDMSO

Simvastatinispreparedinvehicle(DMSO0.1%)[7].

*"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">

References

  • [1].Slater,E.E.,etal.MechanismofactionandbiologicalprofileofHMGCoAreductaseinhibitors.Anewtherapeuticalternative.Drugs,1988.36Suppl3:p.72-82.

    [2].Kureishi,Y.,etal.TheHMG-CoAreductaseinhibitorsimvastatinactivatestheproteinkinaseAktandpromotesangiogenesisinnormocholesterolemicanimals.NatMed,2000.6(9):p.1004-10.

    [3].LeungBP,etal.Anovelanti-inflammatoryroleforsimvastatinininflammatoryarthritis.JImmunol.2003Feb1;170(3):1524-30.

    [4].KobayashiM,etal.PreventiveeffectofMK-733(simvastatin),aninhibitorofHMG-CoAreductase,onhypercholesterolemiaandatherosclerosisinducedbycholesterolfeedinginrabbits.JpnJPharmacol.1989Jan;49(1):125-33.

    [5].IshidaF,etal.Comparativeeffectsofsimvastatin(MK-733)andpravastatin(CS-514)onhypercholesterolemiainducedbycholesterolfeedinginrabbits.BiochimBiophysActa.1990Feb23;1042(3):365-73.

    [6].SukhovaGK,etal.Statinsreduceinflammationinatheromaofnonhumanprimatesindependentofeffectsonserumcholesterol.ArteriosclerThrombVascBiol.2002Sep1;22(9):1452-8.

    [7].ZhongzhongLiu,etal.PretreatmentDonorsafterCirculatoryDeathwithSimvastatinAlleviatesLiverIschemiaReperfusionInjuryThroughaKLF2-dependentMechanisminRat.OxidMedCellLongev.24July2017.

Purity:99.71%